Page 463 - IJB-10-5
P. 463

International Journal of Bioprinting                            3D-printed plasma devices for decontamination













































            Figure 8. Viral genome copy reduction after cold atmospheric plasma (CAP) treatment for (A) SARS-CoV-2; (B) influenza A H1N1; (C) adenovirus; and
            (D) rhinovirus. The viral inoculum was spotted on parafilm, air-dried, and subsequently exposed to CAP for specific durations. Residual virus nucleic
            acid copies (genome equivalents) were determined via quantitative polymerase chain reaction (qPCR). The results are plotted as relative percentages to
            untreated control samples. The average of three biological replicates with the standard error of the mean are displayed for all the measurements. Increasing
            the duration of CAP exposure resulted in a progressive reduction of viral copy numbers, and optimized devices 2 and 3 were superior to original device 1.
            If complete elimination of infectivity was achieved, residual virus nucleic acid copies were not analyzed at longer exposure times (n.a.).


            copies determined by validated qPCR  were reduced   potential for decontaminating various sensitive surfaces
                                             56
            at a slower pace than infectivity (Figure 8C; Table S3).   from pathogens. It features high effectiveness, nontoxic
            Additionally, the efficiency of device 3 was superior to   byproducts, minimal side effects, and operates under
            that of device 2.                                  favorable conditions, including low temperatures. CAP
                                                               can  be  used  continuously and  is  amenable  to  human
            3.5. CAP-mediated decontamination of               applications. The effects of CAP on biological samples
            3D-printed material                                depend on the plasma-generating device used, and 3D
            To assess the ability and efficacy of CAP in decontaminating   printing offers the required flexibility to facilitate the
            3D-printed materials, a proof-of-concept experiment was   production of optimized instruments. Production is
            conducted in which 3D-printed PETG contaminated with   regulated by several critical factors, including construction
            E. coli was tested. Consistent with our earlier findings,   (geometry) and technical parameters, such as applied
            exposure to CAP facilitated complete inactivation of the   power, voltage, and waveform. Furthermore, ambient
            bacteria within 5 min (Figure S3).                 conditions during application, such as the atmospheric

            4. Discussion                                      composition, humidity, and pressure, influence the efficacy
                                                               of CAP.  Hence, improving the design of 3D-printed
                                                                     29
            Cold atmospheric plasma (CAP) is regarded as a     devices, operating conditions, and parameters for the
            groundbreaking disinfection technology with vast   practical application of CAP is essential.


            Volume 10 Issue 5 (2024)                       455                                doi: 10.36922/ijb.3679
   458   459   460   461   462   463   464   465   466   467   468